Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ULTRAGENYX PHARMACEUTICAL INC.

(RARE)
  Report
Delayed Nasdaq  -  04:00 2022-12-09 pm EST
40.65 USD   -1.36%
11/29Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-29-2022 10:00 AM
CI
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on ULTRAGENYX PHARMACEUTICAL INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) ULTRAGENYX PHARMACEUTICAL INC.
Analyst Recommendations on ULTRAGENYX PHARMACEUTICAL INC.
11/03Credit Suisse Adjusts Ultragenyx Pharmaceutical's Price Target to $96 From $105, Keeps Out..
MT
11/03Baird Upgrades Ultragenyx Pharmaceutical to Outperform From Neutral, Adjusts Price Target ..
MT
11/03Wedbush Lowers Ultragenyx Pharmaceutical's PT to $49 From $51, Says Waiting for Additional..
MT
10/13Wedbush Cuts Price Target on Ultragenyx Pharmaceutical to $51 From $68, Maintains Neutral ..
MT
10/13Guggenheim Upgrades Ultragenyx Pharmaceutical to Buy From Neutral; Price Target is $50
MT
08/23Goldman Sachs Adjusts Price Target on Ultragenyx Pharmaceutical to $74 From $72, Reiterate..
MT
08/03Citigroup Adjusts Price Target on Ultragenyx Pharmaceutical to $142 From $146, Reiterates ..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 40,65 $
Average target price 97,00 $
Spread / Average Target 139%
High Price Target 143,00 $
Spread / Highest target 252%
Low Price Target 49,00 $
Spread / Lowest Target 20,5%
Consensus detail
Consensus revision (last 18 months)